Lord, Abbett & Co
ELV icon

Lord, Abbett & Co’s Elevance Health ELV Stock Holding History

Lord, Abbett & Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-197,668
Closed -$95.4M – 575
2022
Q2 		$95.4M Buy
+197,668
New +$97.8M 0.34% 76
2020
Q4 		– Sell
-116,241
Closed -$31.2M – 666
2020
Q3 		$31.2M Sell
116,241
-29,499
-20% -$7.94M 0.1% 297
2020
Q2 		$38.3M Sell
145,740
-45,376
-24% -$12.1M 0.13% 245
2020
Q1 		$43.4M Sell
191,116
-20,874
-10% -$5.69M 0.19% 164
2019
Q4 		$64M Sell
211,990
-13,328
-6% -$3.67M 0.21% 140
2019
Q3 		$54.1M Sell
225,318
-6,511
-3% -$1.78M 0.18% 172
2019
Q2 		$65.4M Buy
231,829
+155
+0.1% +$42.3K 0.21% 158
2019
Q1 		$66.5M Sell
231,674
-8,169
-3% -$2.36M 0.22% 139
2018
Q4 		$63M Buy
239,843
+216,143
+912% +$59.4M 0.23% 129
2018
Q3 		$6.5M Buy
23,700
+8,700
+58% +$2.26M 0.02% 696
2018
Q2 		$3.57M Buy
+15,000
New +$3.47M 0.01% 782
2017
Q2 		– Sell
-211,100
Closed -$34.9M – 891
2017
Q1 		$34.9M Sell
211,100
-43,700
-17% -$6.95M 0.1% 304
2016
Q4 		$36.6M Sell
254,800
-36,700
-13% -$4.91M 0.11% 273
2016
Q3 		$36.5M Buy
291,500
+95,500
+49% +$12.3M 0.11% 293
2016
Q2 		$25.7M Buy
196,000
+162,300
+482% +$22.2M 0.08% 361
2016
Q1 		$4.68M Sell
33,700
-5,100
-13% -$682K 0.01% 716
2015
Q4 		$5.41M Buy
38,800
+14,500
+60% +$2M 0.02% 721
2015
Q3 		$3.4M Sell
24,300
-45,300
-65% -$6.81M 0.01% 794
2015
Q2 		$11.4M Buy
69,600
+1,400
+2% +$224K 0.03% 617
2015
Q1 		$10.5M Buy
68,200
+7,700
+13% +$1.1M 0.03% 614
2014
Q4 		$7.6M Buy
+60,500
New +$7.48M 0.02% 654
2013
Q3 		– Sell
-156,900
Closed -$12.8M – 1043
2013
Q2 		$12.8M Buy
+156,900
New +$11.7M 0.03% 585

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Lord, Abbett & Co's ELV Position: Q3 2022 in Review

Lord, Abbett & Co sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 197,668 shares — an estimated $95.4M sold.

Lord, Abbett & Co first reported a position in ELV in Q2 2013 and held it in 22 quarters. The position peaked at $95.4M in Q2 2022. 1,447 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • Lord, Abbett & Co reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
  • Lord, Abbett & Co sold 197,668 Elevance Health shares in Q3 2022, an estimated $95.4M.
  • Lord, Abbett & Co first reported a position in Elevance Health in Q2 2013 and held it in 22 quarters.
  • Lord, Abbett & Co's Elevance Health position peaked at $95.4M in Q2 2022.
  • 1,447 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Lord, Abbett & Co's 13F filing for Q3 2022, filed 14 Nov 2022.